drugset / Trial / NCT00637585

Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine

NCT00637585

Phase 4 Completed 42 enrolled Sanofi
RandomizedCrossoverDouble-blindTreatment

Summary

To examine the relative potency, onset of action and duration of action of fexofenadine HCl 180 mg (ALLEGRA) and desloratadine 5 mg (CLARINEX) as compared to placebo on skin wheals and flares induced by histamine.

Timeline

Start
2002-12
Primary completion
Completion
2003-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Fexofenadine Unknown 180 mg

Indications